Latest stories on SCNX
Scienture (SCNX) Locks in Exclusive Distribution Channel for REZENOPY Across About 2,000 Opioid Treatment Program Clinics
September 22, 2026
MarketChameleon67 · bullishproduct/pr
Scienture expands commercial reach of Rexenopy to Addiction Treatment Centers
The Fly63 · neutralproduct/pr
SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
Business Insider63 · neutralproduct/pr
SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
GlobeNewswire63 · neutralproduct/pr
Scienture Holdings, Inc. (SCNX) files 8-K
SEC 8-K50 · neutralgeneral
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026
GlobeNewswire56 · neutralproduct/pr
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026
Business Insider56 · neutralproduct/pr
Scienture Holdings, Inc. (SCNX) files 8-K
SEC 8-K50 · neutralgeneral
Scienture announces commercial launch of Rezenopy Nasal Spray
The Fly63 · neutralproduct/pr
Scienture Holdings Q2 non-GAAP EPS of -$0.07, revenue of $0.34M
Seeking Alpha34 · bearishearnings
SCIENTURE’s REZENOPY Launch Expands Access to High-Dose Opioid Overdose Treatment Across the U.S.
MarketChameleon67 · bullishproduct/pr
SCIENTURE Launches REZENOPY as Second FDA-Approved Commercial Product
InvestorsHub67 · bullishproduct/pr
SCIENTURE Launches REZENOPY as Second FDA-Approved Commercial Product
Yahoo Finance67 · bullishproduct/pr
SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray
Business Insider67 · bullishproduct/pr
EXCLUSIVE: Scienture Launches Highest-Dose Naloxone Nasal Spray Rezenopy in US
Yahoo Top67 · bullishproduct/pr
SCNX Readies July Shipments of Highest-Dose Naloxone—REZENOPY Targets $144M U.S. Market
MarketChameleon67 · bullishproduct/pr
SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers
Business Insider63 · neutralproduct/pr
EXCLUSIVE: Scienture Expands Coverage For Opioid Overdose Treatment Ahead Of Commercial Launch
Yahoo Finance67 · bullishproduct/pr
SCIENTURE to Present at The Small Cap Showcase & WTR Insights on June 9, 2026, in NYC | SCNX Stock News
StockTitan57 · neutralgeneral
Scienture Holdings, Inc. GAAP EPS of -$0.08 beats by $0.15, revenue of $0.06M
Seeking Alpha63 · neutralearnings